Related Experiment Videos
Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise
M McGurk1, B L Thomas, A G Renehan
1Salivary Gland Service, Department of Oral and Maxillofacial Surgery, Floor 23 Guy's Tower, Guy's Hospital, London Bridge, London SE1 9RT, UK. mark.mcgurk@kcl.ac.uk
British Journal of Cancer
|October 30, 2003
Summary
Extracapsular dissection (ECD) offers a safe alternative to superficial parotidectomy (SP) for most parotid tumors, showing reduced complications without impacting cancer survival rates.
Area of Science:
- Otolaryngology
- Surgical Oncology
- Head and Neck Surgery
Background:
- Superficial parotidectomy (SP) is standard for parotid tumors.
- Extracapsular dissection (ECD) is an alternative with lower morbidity.
- Concerns exist regarding ECD's oncological safety for potentially malignant tumors.
Purpose of the Study:
- To evaluate the oncological outcomes and morbidity of ECD versus SP for parotid tumors.
- To determine if ECD is appropriate for clinically benign parotid tumors that may harbor malignancy.
Main Methods:
- Retrospective analysis of 821 parotid tumor patients over 40 years.
- Tumors classified as 'simple' (clinically benign) or 'complex'.
- Comparison of outcomes (recurrence, survival, morbidity) between ECD and SP groups.
Main Results:
- 32 (5%) clinically benign tumors were malignant on histology.
- No significant difference in 5- and 10-year cancer-specific survival between ECD and SP.
- ECD group showed significantly reduced morbidity (P < 0.001).
- Recurrence rates were similar between surgical approaches.
Conclusions:
- Extracapsular dissection is a viable and oncologically safe alternative to superficial parotidectomy for most parotid tumors.
- ECD offers reduced morbidity without compromising cancer outcomes.
- ECD is recommended for the majority of parotid tumors, including those initially suspected to be benign.